肺炎球菌ワクチン市場：タイプ、適応症、製品、流通別-2023-2030年の世界予測

肺炎球菌ワクチンの世界市場は、2023年に104億1,878万米ドル、CAGR 8.96%で大きく成長し、2030年には190億2,404万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の肺炎球菌ワクチン市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.肺炎球菌ワクチンの世界市場規模および予測は？

2.予測期間中、世界の肺炎球菌ワクチン市場を形成するCOVID-19の阻害要因と影響は？

3.肺炎球菌ワクチンの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.肺炎球菌ワクチンの世界市場における競争戦略は？

5.肺炎球菌ワクチンの世界市場における技術動向と規制の枠組みは？

6.肺炎球菌ワクチンの世界市場における主要ベンダーの市場シェアは？

7.肺炎球菌ワクチンの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 肺炎球菌汚染の蔓延の増加
    • 適切なワクチン接種に関する啓発プログラムの高まり
  • 抑制要因
    • 肺炎球菌ワクチンの開発には多額の費用がかかる
  • 機会
    • 新しい肺炎球菌ワクチンのイントロダクション
    • 成人ワクチン接種における新たな展開
  • 課題
    • ワクチン生産のための臨床試験の処理が遅い
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 肺炎球菌ワクチン市場：タイプ別

• 結合型ワクチン
• 多糖類ワクチン

第7章 肺炎球菌ワクチン市場適応症別

• 気管支炎
• 髄膜炎
• 肺炎
• 敗血症

第8章 肺炎球菌ワクチン市場：製品別

• ニューモバックス23
• プレブナー13
• シンフロリックス

第9章 肺炎球菌ワクチン市場配信別

• 政府当局
• 非政府組織

第10章 南北アメリカの肺炎球菌ワクチン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の肺炎球菌ワクチン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの肺炎球菌ワクチン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. PNEUMOCOCCAL VACCINE MARKET RESEARCH PROCESS
• FIGURE 2. PNEUMOCOCCAL VACCINE MARKET SIZE, 2022 VS 2030
• FIGURE 3. PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
• FIGURE 6. PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 7. PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
• FIGURE 8. PNEUMOCOCCAL VACCINE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. PNEUMOCOCCAL VACCINE MARKET DYNAMICS
• FIGURE 10. PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. PNEUMOCOCCAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. PNEUMOCOCCAL VACCINE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. PNEUMOCOCCAL VACCINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. PNEUMOCOCCAL VACCINE MARKET SIZE, BY POLYSACCHARIDE VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 8. PNEUMOCOCCAL VACCINE MARKET SIZE, BY BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. PNEUMOCOCCAL VACCINE MARKET SIZE, BY MENINGITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMONIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. PNEUMOCOCCAL VACCINE MARKET SIZE, BY SEPSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 13. PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMOVAX23, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. PNEUMOCOCCAL VACCINE MARKET SIZE, BY PREVNAR 13, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. PNEUMOCOCCAL VACCINE MARKET SIZE, BY SYNFLORIX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 17. PNEUMOCOCCAL VACCINE MARKET SIZE, BY GOVERNMENT AUTHORITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. PNEUMOCOCCAL VACCINE MARKET SIZE, BY NON-GOVERNMENTAL ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 54. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 58. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 60. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 62. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 66. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 70. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 74. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 78. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 82. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 86. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 90. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 94. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 98. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 103. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 107. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 111. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 115. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 119. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 123. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 127. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 129. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 131. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 135. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 139. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 143. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 145. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 147. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 149. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 151. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 155. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 159. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 163. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 167. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 171. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 175. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 179. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 183. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 187. PNEUMOCOCCAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 188. PNEUMOCOCCAL VACCINE MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 189. PNEUMOCOCCAL VACCINE MARKET LICENSE & PRICING

The Global Pneumococcal Vaccine Market is forecasted to grow significantly, with a projected USD 10,418.78 million in 2023 at a CAGR of 8.96% and expected to reach a staggering USD 19,024.04 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Pneumococcal Vaccine Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Pneumococcal Vaccine Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Conjugate Vaccines and Polysaccharide Vaccines. The Polysaccharide Vaccines is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Bronchitis, Meningitis, Pneumonia, and Sepsis. The Pneumonia is projected to witness significant market share during forecast period.

Based on Product, market is studied across Pneumovax23, Prevnar 13, and Synflorix. The Pneumovax23 is projected to witness significant market share during forecast period.

Based on Distribution, market is studied across Government Authorities and Non-Governmental Organizations. The Non-Governmental Organizations is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Pneumococcal Vaccine Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pneumococcal Vaccine Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pneumococcal Vaccine Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pneumococcal Vaccine Market?

4. What is the competitive strategic window for opportunities in the Global Pneumococcal Vaccine Market?

5. What are the technology trends and regulatory frameworks in the Global Pneumococcal Vaccine Market?

6. What is the market share of the leading vendors in the Global Pneumococcal Vaccine Market?

7. What modes and strategic moves are considered suitable for entering the Global Pneumococcal Vaccine Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Pneumococcal Vaccine Market, by Type, 2022 vs 2030
• 4.3. Pneumococcal Vaccine Market, by Indication, 2022 vs 2030
• 4.4. Pneumococcal Vaccine Market, by Product, 2022 vs 2030
• 4.5. Pneumococcal Vaccine Market, by Distribution, 2022 vs 2030
• 4.6. Pneumococcal Vaccine Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of pneumococcal contamination
    • 5.1.1.2. Upsurge in the awareness programs regarding the proper vaccination
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the development of pneumococcal vaccines
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of novel pneumococcal vaccines
    • 5.1.3.2. New developments in adult vaccination
  • 5.1.4. Challenges
    • 5.1.4.1. Slow processing of clinical trials for the production of vaccine
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Pneumococcal Vaccine Market, by Type

• 6.1. Introduction
• 6.2. Conjugate Vaccines
• 6.3. Polysaccharide Vaccines

7. Pneumococcal Vaccine Market, by Indication

• 7.1. Introduction
• 7.2. Bronchitis
• 7.3. Meningitis
• 7.4. Pneumonia
• 7.5. Sepsis

8. Pneumococcal Vaccine Market, by Product

• 8.1. Introduction
• 8.2. Pneumovax23
• 8.3. Prevnar 13
• 8.4. Synflorix

9. Pneumococcal Vaccine Market, by Distribution

• 9.1. Introduction
• 9.2. Government Authorities
• 9.3. Non-Governmental Organizations

10. Americas Pneumococcal Vaccine Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Pneumococcal Vaccine Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Pneumococcal Vaccine Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing